Epicardial fat thickness should be evaluated with other inflammatory markers and cardiovascular risk factors

Echocardiography

Volumn 30, Issue 6, 2013, Pages 739-

  Balta, Sevket ^a   Demirkol, Sait ^a   Arslan, Zekeriya ^a   Unlu, Murat ^a   Kucuk, Ugur ^a   Iyisoy, Atila ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN;

ANTIHYPERTENSIVE THERAPY; ARTERIAL STIFFNESS; ARTERY CALCIFICATION; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE SEVERITY; HUMAN; LETTER; PRIORITY JOURNAL; SMOKING;

ADIPOSE TISSUE; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; PERICARDIUM;

EID: 84879723158     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/echo.12196     Document Type: Letter

References (7)

1. Nabati M, Saffar N, Yazdani J, et al. Relationship between epicardial fat measured by echocardiography and coronary atherosclerosis: A single-blind historical cohort study. Echocardiography 2013 Jan 11 [Epub ahead of print].
2. Mansoor A, Salciccioli L, Qureshi G, et al. Echocardiographic determination of epicardial adipose tissue in healthy bonnet macaques. Echocardiography 2010; 27: 180-185.
3. Lai Y-H, Yun C-H, Yang F-S, et al. Epicardial adipose tissue relating to anthropometrics, metabolic derangements and fatty liver disease independently contributes to serum high-sensitivity C-reactive protein beyond body fat composition: A study validated with computed tomography. J Am Soc Echocardiogr 2012; 25: 234-241.
4. Turan MN, Gungor O, Asci G, et al. Epicardial adipose tissue volume and cardiovascular disease in hemodialysis patients. Atherosclerosis 2013; 226: 129-133.
5. Sengul C, Cevik C, Ozveren O, et al. Echocardiographic epicardial fat thickness is associated with carotid intima-media thickness in patients with metabolic syndrome. Echocardiography 2011; 28: 853-858.
6. Demirkol S, Balta S, Unlu M, et al. Evaluation of the mean platelet volume in patients with cardiac syndrome X. Clinics 2012; 67: 1019-1022.
7. Karaman M, Balta S, Ay SA, et al. The comparative effects of Valsartan and Amlodipine on vWf levels and N/L ratio in patients with newly diagnosed hypertension. Clin Exp Hypertens 2013 Jan 4 [Epub ahead of print].